Mats Rånby
- Cancer Research top 1%
- Hematology top 0.5%
- Pulmonary and Respiratory Medicine top 2%
- Cardiology and Cardiovascular Medicine top 5%
- Molecular Biology
- Co-authors
- Joanna ChmielewskaBjörn WimanPer WallénNils BergsdorfB. WimanG MellbringTorbjörn NilssonBo Norrman
- Topics
- Protease and Inhibitor Mechanisms (28 papers)Blood properties and coagulation (18 papers)Blood Coagulation and Thrombosis Mechanisms (17 papers)
In The Last Decade
Mats Rånby
51 papers receiving 2.8k citations
Hit Papers
Peers
Comparison fields: 5 of 120
- Cancer Research 1.5k
- Hematology 1.4k
- Pulmonary and Respiratory Medicine 968
- Cardiology and Cardiovascular Medicine 433
- Molecular Biology 423
Countries citing papers authored by Mats Rånby
This map shows the geographic impact of Mats Rånby's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mats Rånby with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mats Rånby more than expected).
Fields of papers citing papers by Mats Rånby
This network shows the impact of papers produced by Mats Rånby. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mats Rånby. The network helps show where Mats Rånby may publish in the future.
Co-authorship network of co-authors of Mats Rånby
This figure shows the co-authorship network connecting the top 25 collaborators of Mats Rånby. A scholar is included among the top collaborators of Mats Rånby based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mats Rånby. Mats Rånby is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 36 | |
| 2 | 14 | |
| 3 | 20 | |
| 4 | 35 | |
| 5 | 10 | |
| 6 | 17 | |
| 7 | 33 | |
| 8 | 34 | |
| 9 | 3 | |
| 10 | 9 | |
| 11 | 22 | |
| 12 | 27 | |
| 13 | 29 | |
| 14 | 11 | |
| 15 | 16 | |
| 16 | 72 | |
| 17 | 1 | |
| 18 | 167 | |
| 19 | 129 | |
| 20 | Evidence for a rapid inhibitor to tissue plasminogen activator in plasmabreakdown → | 408 |
About Mats Rånby
Mats Rånby is a scholar working on Hematology, Cancer Research and Internal Medicine, having authored 53 papers that have together received 3.1k indexed citations. Recurring topics across this work include Protease and Inhibitor Mechanisms (28 papers), Blood properties and coagulation (18 papers) and Blood Coagulation and Thrombosis Mechanisms (17 papers). The work is most often cited by research in Hematology (1.4k citations), Cancer Research (1.5k citations) and Internal Medicine (238 citations). Mats Rånby has collaborated with scholars based in Sweden, France and Denmark. Frequent co-authors include Joanna Chmielewska, Björn Wiman, Per Wallén, Nils Bergsdorf, B. Wiman, G Mellbring, Torbjörn Nilsson, Bo Norrman, I. Birgitta Sundell and Tomas Lindahl. Their work appears in journals such as Proceedings of the National Academy of Sciences, Journal of Biological Chemistry and Analytical Biochemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.